Afraxis, Dainippon Sumitomo deal

Afraxis and Dainippon's Sunovion Pharmaceuticals Inc. subsidiary partnered to use Afraxis' Enhanced Spine Platform (ESP) to accelerate Sunovion's preclinical CNS drug discovery process. ESP uses measu...